Cargando…
A novel hotspot and rare somatic mutation p.A138V, at TP53 is associated with poor survival of pancreatic ductal and periampullary adenocarcinoma patients
BACKGROUND: Pancreatic Ductal Adenocarcinoma (PDAC) is a cancer of the exocrine pancreas and 5-year survival rates remain constant at 7%. Along with PDAC, Periampullary Adenocarcinoma (PAC) accounts for 0.5–2% of all gastrointestinal malignancies. Genomic observations were well concluded for PDAC an...
Autores principales: | Saha, Gourab, Singh, Richa, Mandal, Argha, Das, Subrata, Chattopadhyay, Esita, Panja, Prasun, Roy, Paromita, DeSarkar, Navonil, Gulati, Sumit, Ghatak, Supriyo, Ghosh, Shibajyoti, Banerjee, Sudeep, Roy, Bidyut, Ghosh, Saurabh, Chaudhuri, Dipankar, Arora, Neeraj, Biswas, Nidhan K., Sikdar, Nilabja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302128/ https://www.ncbi.nlm.nih.gov/pubmed/32552660 http://dx.doi.org/10.1186/s10020-020-00183-1 |
Ejemplares similares
-
Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An Overview
por: Sikdar, Nilabja, et al.
Publicado: (2018) -
DNA methylome in pancreatic cancer identified novel promoter hyper-methylation in NPY and FAIM2 genes associated with poor prognosis in Indian patient cohort
por: Chatterjee, Ankita, et al.
Publicado: (2022) -
Analysis of the whole transcriptome from gingivo-buccal squamous cell carcinoma reveals deregulated immune landscape and suggests targets for immunotherapy
por: Singh, Richa, et al.
Publicado: (2017) -
Computational prediction of the molecular mechanism of statin group of drugs against SARS-CoV-2 pathogenesis
por: Ghosh, Dipanjan, et al.
Publicado: (2022) -
Altered Mitochondrial Signalling and Metabolism in Cancer
por: Chattopadhyay, Esita, et al.
Publicado: (2017)